Science Explorer Back to mapMap
Discussion
Company · Columbia · United States

Senex Biotechnology (United States)

senexbio.comROR OpenAlex
Research works
22
▲ 375% vs 2018-21
Citations
1k
46.6 per fractional work
Top-10% rate
21.0%
all institutions 10.0%
Open access
39%
world 40%
International
53%
world 18%
Senex Biotechnology (United States)

Not ranked overall: Senex Biotechnology (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Senex Biotechnology (United States) work in?

In all years, 53% of research at Senex Biotechnology (United States) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (31%), Chemistry (6%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 11 fractional works · 53.4% of its workMedicine: 11 fractional works · 53.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 9.9% of its workInfectious Diseases: 2 fractional works · 9.1% of its workOncology: 2 fractional works · 7.0% of its workEpidemiology: 1 fractional works · 5.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.5% of its workHepatology: 1 fractional works · 4.3% of its workPathology and Forensic Medicine: 1 fractional works · 2.9% of its workPharmacology: 1 fractional works · 2.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 2.0% of its workImmunology and Allergy: 0 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.8% of its workReproductive Medicine: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.7% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workLife Sciences: 8 fractional works · 35.1% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 30.7% of its workMolecular Biology: 5 fractional works · 22.8% of its workBiotechnology: 1 fractional works · 3.3% of its workCancer Research: 0 fractional works · 2.1% of its workMolecular Medicine: 0 fractional works · 1.5% of its workGenetics: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 2.0% of its workMicrobiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.7% of its workVirology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 1.5% of its workPlant Science: 0 fractional works · 1.5% of its workNeuroscience: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 11.0% of its workChemistry: 1 fractional works · 5.7% of its workOrganic Chemistry: 1 fractional works · 4.2% of its workSpectroscopy: 0 fractional works · 1.0% of its workAnalytical Chemistry: 0 fractional works · 0.5% of its workEngineering: 1 fractional works · 2.7% of its workElectrical and Electronic Engineering: 0 fractional works · 1.5% of its workCivil and Structural Engineering: 0 fractional works · 0.6% of its workOcean Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnergy: 0 fractional works · 0.9% of its workGeneral Energy: 0 fractional works · 0.9% of its workPhysics and Astronomy: 0 fractional works · 0.8% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.8% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workGeology: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.3% of its workGlobal and Planetary Change: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.5% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workALL ITS WORKSenexBiotechnology…22fractional works, all years
Life Sciences35%Physical Sciences11%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1153.4%
    1. Biochemistry, Genetics and Molecular Biology730.7%
    2. Immunology and Microbiology02.0%
    3. Agricultural and Biological Sciences01.5%
    4. Neuroscience00.8%
    1. Chemistry15.7%
    2. Engineering12.7%
    3. Energy00.9%
    4. Physics and Astronomy00.8%
    5. Materials Science00.3%
    6. Earth and Planetary Sciences00.3%
    7. Environmental Science00.3%
    1. Social Sciences00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.35× its world share, 1 worksBiochemistry, Geneti…Chemistry: 6.49× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.87× its world share, 0 worksEarth and Planetary …Energy: 5.32× its world share, 0 worksEnergyEngineering: 0.40× its world share, 0 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.47× its world share, 0 worksMaterials ScienceMedicine: 2.26× its world share, 2 worksMedicineSocial Sciences: 0.21× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 6.5×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Chemistry6.49×0 works
  2. Biochemistry, Genetics and Molecular Biology5.35×1 works
  3. Energy5.32×0 works
  4. Medicine2.26×2 works
  5. Earth and Planetary Sciences0.87×0 works
  6. Materials Science0.47×0 works
  7. Engineering0.40×0 works
  8. Environmental Science0.27×0 works
  9. Social Sciences0.21×0 works

Who are the top researchers at Senex Biotechnology (United States)?

Ranked on the quality score, Joseph M. Patti and John H. Vernachio lead among researchers whose main affiliation is Senex Biotechnology (United States).

  1. 1 Joseph M. Patti United States · #615,067 worldwide 6.1k citations · 90 works
  2. 2 John H. Vernachio United States · #1,909,875 worldwide 1.4k citations · 30 works
All ranked researchers at Senex Biotechnology (United States)

What are the most cited papers from Senex Biotechnology (United States)?

The most cited paper from Senex Biotechnology (United States) is "Fibronectin Binding Protein and Host Cell Tyrosine Kinase Are Required for Internalization of Staphylococcus aureus by Epithelial Cells" (Katarzyna Dziewanowska, Joseph M. Patti, Claudia F. Deobald et al., 1999), with 296 citations. Next come "Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates" (256) and "Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities" (178).

Most cited papers
#PaperReleasedCitations
1 Fibronectin Binding Protein and Host Cell Tyrosine Kinase Are Required for Internalization of Staphylococcus aureus by Epithelial Cells Katarzyna Dziewanowska, Joseph M. Patti, Claudia F. Deobald et al. · Infection and Immunity Open access Sep 1999 296
2 Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates Kalyan R. Anumula · Analytical Biochemistry 18 Oct 2005 256
3 Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities Donald C. Porter et al. · Proceedings of the National Academy of Sciences Open access 6 Aug 2012 178
4 Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA Andrea E. Hall, Paul J. Domanski, Pratiksha R. Patel et al. · Infection and Immunity Open access 25 Nov 2003 147
5 CDK8/19 Mediator kinases potentiate induction of transcription by NFκB Mengqian Chen, Jiaxin Liang, Hao Ji et al. · Proceedings of the National Academy of Sciences Open access 30 Aug 2017 145
All 55 most cited papers, with filters and sorting

Which keywords describe research at Senex Biotechnology (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Breast Cancer, Cancer Therapy, Immune Response, CDK4/6 Inhibitors, Palbociclib, Glycosylation and Antiviral Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Epidemiology2▲ 2.6×7 topics
  2. Cancer2▲ 6.8×12 topics
  3. Breast Cancer2▲ 31×3 topics
  4. Cancer Therapy2▲ 13×6 topics
  5. Immune Response2▲ 13×6 topics
  6. CDK4/6 Inhibitors2▲ 466×1 topic
  7. Palbociclib2▲ 466×1 topic
  8. Antiviral Therapy2▲ 45×3 topics
  9. Glycosylation2▲ 32×3 topics
  10. Treatment2▲ 5.5×3 topics
  11. Liver Disease1▲ 46×2 topics
  12. Healthcare-Associated Infections1▲ 51×4 topics
  13. Antiretroviral Therapy1▲ 24×2 topics
  14. Drug Resistance1▲ 16×1 topic
  15. HIV Infection1▲ 40×1 topic
  16. Regulation1▲ 8.7×2 topics
  17. Cell Cycle1▲ 84×1 topic
  18. Monoclonal Antibodies1▲ 33×2 topics
  19. Therapeutic Antibodies1▲ 37×2 topics
  20. p531▲ 111×1 topic

Which research topics does Senex Biotechnology (United States) publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Protein Degradation and Inhibitors, Global Energy Security and Policy and Prostate Cancer Treatment and Research.

Advanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksProtein Degradation and Inhibitors: 0 fractional worksGlobal Energy Security and Policy: 0 fractional worksProstate Cancer Treatment and Research: 0 fractional worksHistone Deacetylase Inhibitors Research: 0 fractional worksOvarian cancer diagnosis…0Ovarian cancer diagnosis and treatment: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksPI3K/AKT/mTOR signaling in cancer: 0 fractional worksAnalytical Chemistry and Chromatography: 0 fractional worksMass Spectrometry Techniques and Applications: 0 fractional works
Pulmonary and Respiratory MedicineMolecular BiologyGeneral EnergyReproductive Medicine1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Protein Degradation and Inhibitors Molecular Biology 0 works
  3. 3 Global Energy Security and Policy General Energy 0 works
  4. 4 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  5. 5 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
  6. 6 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  7. 7 Ubiquitin and proteasome pathways Molecular Biology 0 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  9. 9 Analytical Chemistry and Chromatography Spectroscopy 0 works
  10. 10 Mass Spectrometry Techniques and Applications Spectroscopy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.3%not open60.7%

World: 40% of research is openly available.

with international co-authors52.7%domestic only47.3%

World: 18% is written across borders.

How has Senex Biotechnology (United States)'s research output changed?

Output in 2022-2025 was 375% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Senex Biotechnology (United States) as a percentage of every work published that year, 0.000028% in 2024.

still counting0.00010%0.00020%0.00030%Senex Biotechnology (United States)0.0000080% in 20251990200020102020

Fractional works of Senex Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Columbia

All research institutions in Columbia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Senex Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.